ANEMIA FALCIFORME: UMA REVISÃO NARRATIVA DOS AVANÇOS, DESAFIOS E PERSPECTIVAS FUTURAS
Vol. 6 No. 6 (2024), Literature Review
Vol. 6 No. 6 (2024)

ANEMIA FALCIFORME: UMA REVISÃO NARRATIVA DOS AVANÇOS, DESAFIOS E PERSPECTIVAS FUTURAS

Literature Review
https://doi.org/10.36557/2674-8169.2024v6n6p941-957
Published 2024-06-14
Adriane Menezes De Medeiros
Graduando(a) da Universidade Estadual de Mato Grosso do Sul (UEMS)
Giuliane Botareli Cesar
Graduando(a) da Universidade para o Desenvolvimento do Estado e da Região do Pantanal (Uniderp).
Rayhanne Victoria Costa Mota Dutra
Graduando(a) da Universidade para o Desenvolvimento do Estado e da Região do Pantanal (Uniderp).
Giulianna Faypher Morena Vieira Da Silva
Graduando(a) da Universidade Estadual de Mato Grosso do Sul (UEMS)
Selton Nunes Kurmann
Graduando(a) da Universidade Estadual de Mato Grosso do Sul (UEMS)
PDF (Português (Brasil))

Keywords

Anemia; Sickle Cell; Treatment.

How to Cite

Medeiros, A. M. D., Cesar, G. B., Dutra, R. V. C. M., Silva, G. F. M. V. D., & Kurmann, S. N. (2024). ANEMIA FALCIFORME: UMA REVISÃO NARRATIVA DOS AVANÇOS, DESAFIOS E PERSPECTIVAS FUTURAS. Brazilian Journal of Implantology and Health Sciences, 6(6), 941–957. https://doi.org/10.36557/2674-8169.2024v6n6p941-957
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Sickle cell anemia (SCA) is a genetic disease characterized by the presence of hemoglobin S (HbS), leading to the formation of sickle-shaped red blood cells and resulting in a range of clinical complications. This narrative review addresses recent advances in understanding and managing SCA, highlighting general aspects of the disease, nutritional challenges, psychosocial issues, and new therapies. Advances in the understanding of pathophysiology, diagnosis, and treatment, including pharmacological therapies and emerging therapeutic approaches such as gene therapy and genetic editing, offer hope for improving health outcomes and quality of life for patients with SCA. However, persistent challenges such as malnutrition, psychosocial issues, and disparities in access to treatment remain significant obstacles. A multidisciplinary and holistic approach is essential to address these challenges and improve outcomes for individuals affected by this debilitating disease.

https://doi.org/10.36557/2674-8169.2024v6n6p941-957
PDF (Português (Brasil))

References

ELENDU, Chukwuka et al. Understanding Sickle cell disease: Causes, symptoms, and treatment options. Medicine (Baltimore), [S. l.], p. n.p., 22 set. 2023. DOI https://doi.org/10.1097/md.0000000000035237. Disponível em: https://pubmed.ncbi.nlm.nih.gov/37746969/. Acesso em: 12 jun. 2024.

HARDOUIN, Giulia et al. Sickle Cell Disease: From Genetics to Curative Approaches. Annu Rev Genomics Hum Genet., [S. l.], p. 255-275, 25 ago. 2023. DOI https://doi.org/10.1146/annurev-genom-120122-081037. Disponível em: https://pubmed.ncbi.nlm.nih.gov/37624668/. Acesso em: 12 jun. 2024.

OBEAGU, Emmanuel et al. Understanding apoptosis in sickle cell anemia patients: Mechanisms and implications. Medicine (Baltimore), [S. l.], p. n.p., 12 jan. 2024. DOI https://doi.org/10.1097/md.0000000000036898. Disponível em: https://pubmed.ncbi.nlm.nih.gov/38215146/. Acesso em: 12 jun. 2024.

OBEAGU, Emmanuel; OBEAGU, Getrude. Malnutrition in sickle cell anemia: Prevalence, impact, and interventions: A Review. Medicine (Baltimore), [S. l.], p. n.p., 17 maio 2024. DOI https://doi.org/10.1097/md.0000000000038164. Disponível em: https://pubmed.ncbi.nlm.nih.gov/38758879/. Acesso em: 12 jun. 2024.

SILVA, Marisa; FAUSTINO, Paula. From Stress to Sick(le) and Back Again-Oxidative/Antioxidant Mechanisms, Genetic Modulation, and Cerebrovascular Disease in Children with Sickle Cell Anemia. Antioxidants (Basel), [S. l.], p. n.p., 7 nov. 2023. DOI https://doi.org/10.3390/antiox12111977. Disponível em: https://pubmed.ncbi.nlm.nih.gov/38001830/. Acesso em: 12 jun. 2024.

KOSOKO, Adeola et al. Not Just a Pain: A Medical Simulation Case About Biased Communication and Osteomyelitis in Pediatric Sickle Cell Anemia. MedEdPORTAL, [S. l.], p. n.p., 16 ago. 2023. DOI https://doi.org/10.15766/mep_2374-8265.11335. Disponível em: https://pubmed.ncbi.nlm.nih.gov/37593566/. Acesso em: 12 jun. 2024.

BHOOPALAN, Senthil et al. Transplante de células hematopoiéticas e terapia genética para anemia Diamond-Blackfan: estado da arte e ciência. Oncol frontal, [S. l.], p. n.p., 11 set. 2023. DOI https://doi.org/10.3389/fonc.2023.1236038. Disponível em: https://pubmed.ncbi.nlm.nih.gov/37752993/. Acesso em: 12 jun. 2024.

ESSIEN, Emmanuel et al. Psychosocial challenges of persons with sickle cell anemia: A narrative review. Medicine (Baltimore), [S. l.], p. n.p., 29 nov. 2023. DOI https://doi.org/10.1097/md.0000000000036147. Disponível em: https://pubmed.ncbi.nlm.nih.gov/38013366/. Acesso em: 12 jun. 2024.

BELL, Victoria et al. Sickle Cell Disease Update: New Treatments and Challenging Nutritional Interventions. Nutrients, [S. l.], p. n.p., 15 jan. 2024. DOI https://doi.org/10.3390/nu16020258. Disponível em: https://pubmed.ncbi.nlm.nih.gov/38257151/. Acesso em: 12 jun. 2024.

ABODERIN, Florence et al. A Review of the Relationship between the Immune Response, Inflammation, Oxidative Stress, and the Pathogenesis of Sickle Cell Anaemia. Biomedicines, [S. l.], p. n.p., 29 ago. 2023. DOI https://doi.org/10.3390/biomedicines11092413. Disponível em: https://pubmed.ncbi.nlm.nih.gov/37760854/. Acesso em: 12 jun. 2024.

CAMPO, Joshua et al. Overview of the management and prognosis of sickle cell disease Topic Graphics (4). UpToDate, [S. l.], p. n.p., 1 maio 2024. Disponível em: https://www.uptodate.com/contents/overview-of-the-management-and-prognosis-of-sickle-cell-disease. Acesso em: 13 jun. 2024.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Adriane Menezes De Medeiros, Giuliane Botareli Cesar, Rayhanne Victoria Costa Mota Dutra, Giulianna Faypher Morena Vieira Da Silva, Selton Nunes Kurmann